Legislation passed by the Energy and Commerce Committee could increase the number of people without health insurance by 8.6 million, due largely to changes to Medicaid and the ACA. Combining the provisions with the effect of the expected expiration of the ACA’s enhanced premium tax credits, CBO expects 13.7 million more people will be uninsured…
As the 2024 presidential election draws near, there are sharp differences in former President Trump’s and Vice President Harris’ records on health coverage and spending, including the Affordable Care Act, Medicaid, prescription drugs, and more. At Noon ET on Tuesday, October 1, Larry Levitt, KFF’s executive vice president for health policy, will moderate a 45-minute…More
Isomorphic Labs’ financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector. Biotech financing activity has been slowing down, analysts say. The post An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025 appeared first on MedCity News.
The Supreme Court will soon hear oral arguments for a case that threatens coverage of preventive services without cost-sharing. Experts say this could make it significantly harder for patients to access care and lead to higher costs down the road. The post How the Pending Supreme Court Decision on Preventive Care Could Affect the Healthcare…
Vor Bio is licensing global rights a fusion protein that inhibits two targets to potentially treat the neuromuscular disorder generalized myasthenia gravis. It’s a pivot for Vor, which last month ceased its cancer R&D and announced it would explore strategic alternatives. The post Vor Bio Reinvents Itself as an Autoimmune Biotech With In-Licensed Phase 3…
Check out news from Oral Genome, DataJoint, Health Wildcatters, and more. The post StartUPDATES: New Developments for Healthcare Startups appeared first on MedCity News.
Data only drives change when the right people see the right numbers at the right time and someone owns the follow-through. The post Bridging the Gap Between Data and Quality Improvement for Hospitals appeared first on MedCity News.
A new poll has industry leaders warning that tariffs will disrupt U.S. healthcare costs and supply chain stability
I got to interview V Bento the CEO of Sword Health. We had been in a little back and forth on Linkedin but this was the first time we actually had talked. Almost all of their business is in the US in MSK but they have recently added mental health and V is not shy…
The combination of Bristol Myers Squibb cancer drugs Opdivo and Yervoy landed FDA approvals for the first-line treatment of colorectal cancer and hepatocellular carcinoma. Several other products also expanded their approved uses in our recap of recent regulatory news. The post BMS Immunotherapy Combo Gets Two FDA Nods for GI Cancers in Span of a…